422 related articles for article (PubMed ID: 26862355)
1. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.
Ali AS; Al-Shraim M; Al-Hakami AM; Jones IM
Open Virol J; 2015; 9():7-28. PubMed ID: 26862355
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
Young LS; Murray PG
Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus: biology and disease.
Cruchley AT; Williams DM; Niedobitek G; Young LS
Oral Dis; 1997 May; 3 Suppl 1():S156-63. PubMed ID: 9456681
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors.
Rea D; Delecluse HJ; Hamilton-Dutoit SJ; Marelle L; Joab I; Edelman L; Finet JF; Raphael M
Ann Oncol; 1994; 5 Suppl 1():113-6. PubMed ID: 8172807
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated lymphoproliferative disorders.
Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Epstein-Barr Virus infection in immunocompromised patients.
Pociupany M; Snoeck R; Dierickx D; Andrei G
Biochem Pharmacol; 2024 May; 225():116270. PubMed ID: 38734316
[TBL] [Abstract][Full Text] [Related]
9. EBV Association with Lymphomas and Carcinomas in the Oral Compartment.
Ward BJH; Schaal DL; Nkadi EH; Scott RS
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560704
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.
Kikuchi K; Inoue H; Miyazaki Y; Ide F; Kojima M; Kusama K
Jpn Dent Sci Rev; 2017 Aug; 53(3):95-109. PubMed ID: 28725300
[TBL] [Abstract][Full Text] [Related]
13. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
Gutierrez MI; Bhatia K; Magrath I
Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus: the first human tumor virus and its role in cancer.
Pagano JS
Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
[TBL] [Abstract][Full Text] [Related]
15. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.
van Beek J; Brink AATP; Vervoort MBHJ; van Zijp MJM; Meijer CJLM; van den Brule AJC; Middeldorp JM
J Gen Virol; 2003 Oct; 84(Pt 10):2647-2659. PubMed ID: 13679598
[TBL] [Abstract][Full Text] [Related]
16. Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans.
Ayee R; Ofori MEO; Wright E; Quaye O
J Cancer; 2020; 11(7):1737-1750. PubMed ID: 32194785
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection: basis of malignancy and potential for therapy.
Murray PG; Young LS
Expert Rev Mol Med; 2001 Nov; 3(28):1-20. PubMed ID: 14585152
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
19. The Global Landscape of EBV-Associated Tumors.
Shannon-Lowe C; Rickinson A
Front Oncol; 2019; 9():713. PubMed ID: 31448229
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
